GSK-3β-IN-29 is a selective GSK-3β inhibitor with an IC 50 of 34.0 nM. GSK-3β-IN-29 shows selectivity for GSK-3β over 40 other kinases and for 5-HT1 a receptor. GSK-3β-IN-29 exhibits neuroprotection in mice. GSK-3β-IN-29 can be used for the research of nervous system (CNS) disorders.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > GSK-3
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.